Est. 2001·3,000+ placements · six offices · four regions

Company signals · Digital Health

Doximity

2 signals in the current window, with MitchelLake's leadership read on each.

Last updated

Market context: Backdrop: a 103.9 (Hot) Talent Market Index (down 1.9 on the month) with Americas activity rising (+2.1pts).

Doximity: 2 signals in the last 90 days — above the Digital Health median of 1 across 59 tracked companies; 0.1% of MitchelLake's Americas signal flow; 2 tracked across 56 days.

Signals at Doximity

Product Launch

Americas

Doximity is expanding AI investment with 165 signed health system AI clients, signaling active product development and market adoption of AI capabilities in healthcare.

Leadership read: Doximity's launch shifts talent demand before revenue catches up. In Digital Health, taking a release to scale rewards product leaders with a commercial edge and operators who build the post-launch motion. Watch whether Doximity backs it with senior go-to-market hires across Americas — that separates a platform move from a one-off.

curated · 2026-08-07 · context →

Restructuring

Americas

Doximity facing significant challenges including May 2026 earnings miss, management flagging near-term margin pressure from AI spending increases, 23% single-day share drop, and ongoing securities law investigation

Leadership read: Doximity's earnings miss is less about a single quarter than about what management disclosed alongside it: AI infrastructure spending is now large enough to compress margins visibly, and the company said so publicly. That admission commits the business to a harder trade-off than it faced before — sustaining physician network depth and pharma-client retention while absorbing a cost base that is structurally higher than the one that built the margin profile investors priced. The securities investigation, whatever its outcome, adds a disclosure and governance overhead that management attention must now absorb in parallel with the operational reset. This is one of twelve restructuring signals we have tracked across sectors in the last 90 days. The comparables here are thematically thin — Luno's 20% workforce cut pivoting toward institutional clients and Tokuyama's margin compression story are adjacent in dynamic if not in sector. The more relevant pattern is the one forming specifically in enterprise SaaS and health-tech: AI spend is moving from discretionary R&D line to core infrastructure, and the resulting margin pressure is landing on the income statement faster than revenue uplift from those investments. Doximity is an early and visible data point in that pattern. Companies at this stage of AI-infrastructure commitment in vertical SaaS face rising demand for leadership at the intersection of product economics and commercial execution — specifically, operators who can manage the latency between cost commitment and monetisable output, and finance and product leaders who can communicate that gap credibly to institutional investors navigating the securities-risk dimension simultaneously.

curated · 2026-06-12 · context →

More signals across Digital Health

Ma Activity · Americas

Acentra Health

Acentra Health acquired FEI Systems to expand its technology and clinical capabilities across Medicaid, long-term services and supports (LTSS), home- and community-based services (HCBS), and behavioral health verticals.

Product Launch · Americas

Hims & Hers

Hims & Hers launched Biotin + Minoxidil Gummy (June 2025), its first prescription gummy product, targeting wellness-focused consumers with CPG-style packaging and form factors. The product is reporting high adherence rates.

Product Launch · Americas

PulsePoint

PulsePoint launched Hatch, an agentic AI platform purpose-built for healthcare marketing with conversational capabilities integrated into proprietary health data foundation

Product Launch · Americas

Labcorp

Labcorp launched the first FDA-approved IHC assay (PTEN companion diagnostic) for prostate cancer, enabling patient identification for combination treatment with capivasertib (TRUQAP®)

Product Launch · Americas

Signant Health

Signant Health launched Forecasting & Planning Assist™, an agentic AI capability designed for clinical supply chain forecasting and planning, leveraging latest AI advances.

Ma Activity · Americas

Hippocratic AI

Hippocratic AI acquired Grove AI, a startup formed in 2024 that uses voice agents to recruit eligible patients for clinical trials. The acquisition occurred in 2026, approximately 2 years after Grove AI's founding.

Weekly briefing

Track companies like Doximity — with our analysis

Anyone can set an alert for one company. We send a weekly read on the whole peer set — who's moving, and what it means for leadership. Pick what to follow:

Intelligence powered by Autonodal ↗

Nearby in the record